← All themes
Biotech (new drugs) stocks
바이오 신약
What are Biotech (new drugs) stocks in Korea?
The Biotech (new drugs) theme on jonbur groups 204 Korean stocks listed on KOSPI and KOSDAQ, worth ₩221T in total. On Oct 28, 2026 the group moved up 0.68% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.
Key facts
- Stocks
- 204
- Total market value
- ₩221T
- Day's move
- +0.68%
- As of
- Oct 28, 2026
- Largest members
- Samsung Biologics, Celltrion, Alteogen
Earnings tracker · 4Q 2025
Past quarter
180 of 208 reportedOperating profit up vs a year ago: 93 of 168
Revenue−0.1%
Operating profit+246.2%
Net profit+2,977.8%
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| Samsung Biologics | Mar 12 | ₩309B | −75.4% | ₩378B | +16.1% | −48.1% | 122.5%25.9% |
| Celltrion | Mar 16 | ₩1.3T | +25.1% | ₩475B | +141.9% | +57.6% | 35.7%18.5% |
| Alteogen | Mar 23 | ₩65B | +26.9% | ₩20B | −14.7% | −26.4% | 30.4%45.3% |
| SK biopharmaceuticals | Mar 18 | ₩194B | +19.2% | ₩46B | +13.8% | −34.0% | 23.8%24.9% |
| Yuhan | Mar 12 | ₩546B | +10.1% | ₩26B | Turned to profit | +18.5% | 4.8%−2.4% |
| HLB | Mar 23 | ₩29B | +13.6% | −₩29B | Bigger loss | Bigger loss | −102.5%−101.9% |
| Hanmi Pharm | Mar 20 | ₩433B | +23.1% | ₩83B | +173.4% | +51.2% | 19.2%8.7% |
| Hanmi Science | Mar 20 | ₩344B | +3.7% | ₩38B | +198.6% | −4.0% | 11.0%3.8% |
| SK Bioscience | Mar 13 | ₩184B | +17.4% | −₩52B | Bigger loss | Bigger loss | −28.0%−32.4% |
| PharmaResearch | Mar 19 | ₩143B | +39.1% | ₩52B | +54.1% | −16.1% | 36.2%32.7% |
| ABL Bio | Mar 12 | ₩0 | −100.0% | −₩30B | Bigger loss | Bigger loss | — |
| Hugel | Mar 20 | ₩119B | +21.3% | ₩58B | +24.5% | +22.0% | 48.5%47.3% |
| Peptron | Mar 18 | ₩987M | −36.1% | −₩5.7B | Bigger loss | Smaller loss | −576.4%−227.4% |
| Voronoi | Mar 20 | ₩22M | Turned to profit | −₩16B | Bigger loss | Bigger loss | −73,336.0% |
| OliX Pharmaceuticals | Mar 18 | ₩4.5B | +9,920.3% | −₩8.5B | Bigger loss | Bigger loss | −186.7%−16,826.5% |
| Hanall Biopharma | Mar 18 | ₩38B | +3.1% | −₩2B | Turned to loss | Turned to loss | −5.4%7.5% |
| D&D Pharmatech | Mar 20 | ₩990M | −80.4% | −₩10B | Bigger loss | Bigger loss | −1,051.6%−135.7% |
| Caregen | Mar 16 | ₩16B | −23.6% | −₩7.1B | Turned to loss | Turned to loss | −43.4%28.7% |
| Mezzion Pharma | Mar 20 | ₩2.1B | +8.3% | −₩5.1B | Bigger loss | Bigger loss | −242.3%−206.6% |
| ST Pharm | Mar 18 | ₩129B | +11.5% | ₩26B | +15.3% | +78.4% | 20.3%19.7% |
| Seegene | Mar 19 | ₩131B | +13.3% | ₩6.9B | Turned to profit | −27.7% | 5.3%−5.4% |
| GC Biopharma | Mar 18 | ₩498B | +12.9% | ₩4.6B | Turned to profit | −84.3% | 0.9%−2.3% |
| Naturecell | Mar 23 | ₩6.4B | −17.9% | −₩261M | Turned to loss | Smaller loss | −4.1%2.5% |
| OSCOTECInc | Mar 19 | ₩79B | +3,279.3% | ₩61B | Turned to profit | Turned to profit | 77.8%−301.2% |
| Aimed Bio | Mar 19 | ₩38B | — | ₩26B | — | — | 67.2% |
| Kolon TissueGene | Mar 18 | ₩585,091 | +7.3% | −₩5.6M | Bigger loss | Bigger loss | −950.1%−853.3% |
| Daewoong Pharma | Mar 18 | ₩397B | +7.9% | ₩43B | +12.0% | −23.8% | 10.9%10.5% |
| Curiox Biosystems | Mar 23 | ₩1.8B | +93.5% | −₩2.7B | Smaller loss | Smaller loss | −143.4%−379.6% |
| Chong Kun Dang Pharmaceutical | Mar 18 | ₩427B | +2.7% | ₩23B | +247.1% | +11.9% | 5.5%1.6% |
| JS Link | Mar 23 | ₩8.9B | +55.7% | −₩1.4B | Smaller loss | Smaller loss | −16.3%−30.0% |
| Qurient | Mar 18 | ₩1.5B | −45.8% | −₩9.3B | Bigger loss | Bigger loss | −606.2%−276.1% |
| L&C Bio | Mar 24 | ₩25B | +29.2% | ₩2B | Turned to profit | −32.5% | 7.9%−3.3% |
| Chabiotech | Mar 20 | ₩347B | +25.6% | −₩7.4B | Smaller loss | Smaller loss | −2.1%−14.3% |
| Rznomics | Mar 23 | ₩830M | Turned to profit | −₩5.4B | Bigger loss | Smaller loss | −655.8% |
| G2GBIO | Mar 18 | ₩203M | Turned to profit | −₩3B | Smaller loss | Smaller loss | −1,485.0% |
| Pharmicell | Mar 18 | ₩35B | +61.2% | ₩9.6B | +206.1% | +18.1% | 27.8%14.6% |
| Onconic Therapeutics | Mar 13 | ₩16B | — | ₩1.6B | — | −80.6% | 10.3% |
| Proteina | Mar 20 | ₩343M | — | −₩4.4B | — | Bigger loss | −1,295.4% |
| JW Pharmaceutical | Mar 18 | ₩199B | +5.9% | ₩15B | −14.4% | −51.7% | 7.8%9.6% |
| Hyundai Bioscience | Mar 18 | ₩1.9B | +426.0% | −₩4.4B | Bigger loss | Smaller loss | −230.9%−766.7% |
| Medy-Tox | Mar 19 | ₩61B | +10.0% | −₩3.7B | Turned to loss | Turned to loss | −6.1%1.7% |
| BioNote | Mar 18 | ₩28B | +13.0% | ₩840M | −67.0% | −82.6% | 3.0%10.3% |
| GI Innovation | Mar 18 | ₩5.5B | Turned to profit | −₩7.2B | Smaller loss | Smaller loss | −130.7% |
| Shinpoong Pharmaceutical | Mar 20 | ₩58B | +5.0% | ₩3.9B | Turned to profit | −46.4% | 6.7%−21.9% |
| GC | Mar 18 | ₩619B | +9.6% | −₩6.7B | Smaller loss | Turned to loss | −1.1%−4.4% |
| Penetrium Bioscience | — | ₩1.9B | −20.9% | −₩1.6B | Smaller loss | Bigger loss | −80.4%−75.0% |
| AbClon | Mar 13 | ₩1.6B | +128.6% | −₩5B | Bigger loss | Bigger loss | −308.4%−457.3% |
| GemVax & KAEL | Mar 20 | ₩26B | +43.2% | ₩7.5B | Turned to profit | +923.0% | 28.7%−44.7% |
| HLB Life Science | Mar 23 | ₩11B | −61.8% | −₩5.8B | Smaller loss | Bigger loss | −53.0%−23.9% |
| IL Dong Pharmaceutical | Mar 18 | ₩147B | −5.6% | ₩7.9B | −5.7% | +17.2% | 5.4%5.4% |
| Curocell | Mar 19 | ₩0 | Flat | −₩8.7B | Smaller loss | Smaller loss | — |
| Bukwang Pharmaceutical IND | Mar 16 | ₩63B | +35.4% | ₩8.2B | +317.8% | +733.2% | 13.0%4.2% |
| Orum Therapeutics | Mar 19 | ₩558,176 | — | −₩18B | — | Bigger loss | −3,270,387.0% |
| AprilBio | Mar 13 | ₩0 | −100.0% | −₩2B | Turned to loss | Smaller loss | — |
| Medipostco | Mar 19 | ₩18B | +0.4% | −₩21B | Bigger loss | Bigger loss | −118.7%−105.1% |
| Dong-A ST | Mar 18 | ₩217B | +21.4% | −₩2.7B | Smaller loss | Turned to loss | −1.3%−4.1% |
| SillaJen | Mar 19 | ₩2.9B | +90.7% | −₩8.2B | Bigger loss | Bigger loss | −280.2%−490.0% |
| ToolGen | Mar 19 | ₩404M | +138.3% | −₩6.9B | Bigger loss | Bigger loss | −1,716.9%−3,346.5% |
| EuBiologics | Mar 17 | ₩32B | −12.2% | ₩14B | −18.1% | −28.0% | 42.1%45.1% |
| NKGen Biotech Korea | Mar 24 | ₩2.2B | −0.8% | −₩1.3B | Turned to loss | Turned to loss | −61.0%204.6% |
| ImmuneOncia Therapeutics | Mar 18 | ₩0 | — | −₩9.6B | — | Smaller loss | — |
| Genomictree | Mar 18 | ₩826M | +0.1% | −₩2.6B | Smaller loss | Smaller loss | −317.5%−443.3% |
| Q AID | Mar 19 | ₩22B | −21.5% | −₩687M | Turned to loss | Smaller loss | −3.2%57.5% |
| S.Biomedics | Mar 24 | ₩4B | −9.4% | −₩2.7B | Bigger loss | Bigger loss | −66.4%−24.9% |
| FutureChem | Mar 18 | ₩6.2B | −1.2% | −₩1.4B | Smaller loss | Smaller loss | −22.9%−37.9% |
| HLB Therapeutics | Mar 19 | ₩23B | +38.4% | ₩4.1B | +25,714.7% | Turned to profit | 18.0%0.1% |
| IntoCell | Mar 18 | ₩728M | +547.5% | −₩1.9B | Smaller loss | Bigger loss | −256.8%−1,895.2% |
| Jetema | Mar 20 | ₩20B | +7.1% | ₩1.2B | Turned to profit | +15.2% | 5.8%−0.1% |
| BioPlus | Mar 20 | ₩23B | −20.3% | ₩963M | −93.0% | −80.3% | 4.2%47.5% |
| DuChemBio | Mar 18 | ₩11B | — | ₩3B | — | +57.1% | 27.9% |
| Genome&Company | Mar 20 | ₩5.9B | −18.9% | −₩7B | Bigger loss | Smaller loss | −119.8%−73.5% |
| GC Genome | Mar 16 | ₩8.1B | — | ₩201M | — | −74.0% | 2.5% |
| Binex | Mar 13 | ₩39B | +7.9% | −₩6.3B | Smaller loss | Turned to loss | −16.3%−19.8% |
| 3billion | Mar 23 | ₩3.9B | — | −₩1.1B | — | Smaller loss | −27.3% |
| HEM Pharma | Mar 18 | ₩3.7B | −41.9% | −₩6.8B | Bigger loss | Bigger loss | −184.1%−31.4% |
| Bioneercorporation | Mar 24 | ₩80B | +13.4% | ₩2.7B | Turned to profit | −6.4% | 3.4%−10.5% |
| curacle | Mar 18 | ₩0 | −100.0% | −₩4.7B | Bigger loss | Bigger loss | — |
| Vivozon Pharmaceutical | — | ₩16B | −30.3% | −₩3.7B | Turned to loss | Smaller loss | −23.0%2.2% |
| Kangstem Biotech | Mar 20 | ₩1.1B | −67.6% | −₩4.3B | Bigger loss | Bigger loss | −389.4%−59.1% |
| Helixmith | Mar 20 | ₩490M | −70.0% | −₩2.4B | Bigger loss | Smaller loss | −484.2%−76.8% |
| BNC Korea | Mar 23 | ₩24B | −8.6% | −₩2.4B | Turned to loss | Bigger loss | −10.0%6.7% |
| Kolon Life Science | Mar 18 | ₩45B | −4.6% | −₩2.7B | Smaller loss | Turned to loss | −6.0%−6.9% |
| Eone Diagnomics Genome Center | Mar 24 | ₩1.7B | −70.3% | −₩359M | Smaller loss | Smaller loss | −21.2%−73.3% |
| GC Cell | Mar 16 | ₩38B | −10.8% | −₩4.3B | Smaller loss | Bigger loss | −11.4%−21.8% |
| Aptabio Therapeutics | Mar 23 | ₩1B | +34.6% | −₩5.7B | Smaller loss | Bigger loss | −569.3%−887.7% |
| Cellbion | Mar 20 | ₩382M | −32.6% | −₩2.5B | Bigger loss | Bigger loss | −657.6%−385.7% |
| ISU Abxis | Mar 12 | ₩11B | −47.1% | −₩7.8B | Turned to loss | Turned to loss | −71.8%25.4% |
| Bio Solution | Mar 19 | ₩4.4B | +23.2% | −₩485M | Bigger loss | Smaller loss | −11.0%−13.3% |
| Y-Biologics | Mar 23 | ₩449M | −60.9% | −₩3B | Bigger loss | Bigger loss | −665.5%−205.9% |
| Aribio Holdings | Mar 18 | ₩15B | +56.7% | ₩342M | Turned to profit | Turned to profit | 2.2%−19.0% |
| Anterogen | Mar 12 | ₩2B | +12.0% | −₩475M | Smaller loss | Bigger loss | −23.7%−71.3% |
| Cell Biotech | Mar 18 | ₩15B | +20.4% | ₩3.1B | +171.0% | +37.8% | 20.9%9.3% |
| JW Shinyak | Mar 18 | ₩21B | +31.2% | ₩1.4B | Turned to profit | −47.2% | 6.7%−17.8% |
| Macrogen | Mar 23 | ₩56B | +37.3% | ₩3.6B | Turned to profit | +226.9% | 6.5%−7.5% |
| TiumBio | Mar 18 | ₩4.4B | +200.1% | −₩2.8B | Smaller loss | Smaller loss | −62.6%−351.5% |
| Keeps Biopharma | Mar 23 | ₩45B | +37.7% | ₩1B | Turned to profit | −30.0% | 2.2%−4.0% |
| ViGenCell | Mar 18 | ₩14M | −93.7% | −₩6.3B | Bigger loss | Bigger loss | −45,073.8%−1,632.9% |
| Celemics | Mar 23 | ₩1.7B | −18.0% | −₩456M | Bigger loss | Smaller loss | −27.5%−7.0% |
| HLB bioStep | Mar 18 | ₩19B | +16.0% | −₩2.2B | Smaller loss | Turned to loss | −11.8%−29.0% |
| Genexine | Mar 11 | ₩537M | +75.6% | −₩13B | Bigger loss | Bigger loss | −2,379.5%−2,499.5% |
| MedPacto | Mar 18 | ₩1.4B | Turned to profit | −₩2.9B | Smaller loss | Smaller loss | −204.4% |
| Asta | Mar 19 | ₩767M | −59.0% | −₩484M | Smaller loss | Smaller loss | −63.0%−43.2% |
| Metabiomed | — | ₩26B | +13.8% | ₩2.9B | −39.3% | −42.2% | 11.2%21.0% |
| Aribiolab | Mar 17 | ₩0 | Flat | −₩5.4B | Bigger loss | Bigger loss | — |
| CHA AI Healthkare | Mar 19 | ₩2B | −21.4% | −₩2B | Bigger loss | Smaller loss | −102.2%−77.4% |
| DreamCIS | Mar 23 | ₩19B | +30.9% | −₩388M | Turned to loss | Turned to loss | −2.0%18.4% |
| iNtRON Biotechnology | Mar 11 | ₩1.7B | +12.0% | −₩2B | Bigger loss | Smaller loss | −119.7%−88.1% |
| Vaxcell-Bio Therapeutics | Mar 16 | ₩1.7B | −5.7% | −₩3.6B | Smaller loss | Bigger loss | −214.9%−241.1% |
| T&R Biofab | Mar 18 | ₩7.5B | +511.9% | −₩2.3B | Smaller loss | Bigger loss | −30.5%−212.6% |
| Corestemchemon | Mar 19 | ₩4.9B | +0.6% | −₩3.1B | Smaller loss | Smaller loss | −62.4%−158.3% |
| Aminologics | Mar 23 | ₩6.5B | +62.3% | ₩1.5B | Turned to profit | +4.4% | 22.4%−9.7% |
| HLB Global | Mar 18 | ₩22B | +5.5% | −₩4.5B | Bigger loss | Bigger loss | −20.5%−11.3% |
| Enzychem Lifesciences | Mar 24 | ₩14B | −23.9% | −₩4.4B | Smaller loss | Bigger loss | −31.1%−25.3% |
| Choong ANG Vaccine Laboratory | Mar 16 | ₩13B | +14.0% | ₩1.1B | +97.0% | −26.1% | 8.9%5.2% |
| Pharos iBio | Mar 19 | — | — | −₩2.9B | Bigger loss | Smaller loss | — |
| HLB Genex | Mar 20 | ₩12B | +24.0% | −₩655M | Smaller loss | Bigger loss | −5.2%−14.5% |
| Polaris AI Pharma | Mar 13 | ₩14B | −12.2% | −₩392M | Smaller loss | Turned to loss | −2.7%−6.8% |
| SCL Science | Mar 23 | ₩8.3B | +419.2% | −₩848M | Smaller loss | Turned to loss | −10.2%−85.5% |
| Eye Gene | Mar 19 | ₩774M | −41.0% | −₩3.3B | Bigger loss | Bigger loss | −420.4%−180.8% |
| Theragen Etex | Mar 19 | ₩69B | +5.3% | ₩4.2B | +75.1% | +117.2% | 6.1%3.7% |
| DongKook Life Science | Mar 12 | ₩31B | — | ₩2.5B | — | −42.6% | 7.9% |
| Choolip & Sciences | Mar 13 | ₩1.8B | +90.8% | −₩1.9B | Bigger loss | Smaller loss | −110.7%−210.8% |
| SunBio | Mar 16 | ₩4.7B | +38.3% | ₩2.1B | +36.5% | +29.9% | 45.0%45.6% |
| Sugentech | Mar 18 | ₩2.9B | +16.4% | −₩5.1B | Smaller loss | Bigger loss | −178.1%−310.7% |
| Naturalendo Tech | Mar 16 | ₩5.2B | +7.3% | −₩831M | Smaller loss | Bigger loss | −16.0%−19.4% |
| CTC Bio | Mar 18 | ₩32B | −22.1% | ₩1.5B | +85.4% | −3.4% | 4.8%2.0% |
| Amicogen | Mar 23 | ₩11B | −80.9% | −₩3.9B | Bigger loss | Smaller loss | −35.8%−1.4% |
| Optipharm | Mar 13 | ₩6B | +6.5% | −₩321M | Bigger loss | Smaller loss | −5.4%−4.5% |
| Pangen Biotech | Mar 23 | ₩2.5B | −42.9% | −₩404M | Bigger loss | Turned to loss | −16.3%−6.4% |
| PharmGen Science | Mar 23 | ₩43B | −3.2% | −₩753M | Turned to loss | Turned to loss | −1.8%4.2% |
| Abion | Mar 19 | ₩66M | −69.5% | −₩5.6B | Smaller loss | Bigger loss | −8,472.1%−4,934.0% |
| Cellid | Mar 23 | ₩2.8B | +49.2% | −₩3.7B | Bigger loss | Bigger loss | −131.1%−191.6% |
| Tego Science | — | ₩1.4B | −13.3% | −₩2.1B | Bigger loss | Bigger loss | −152.1%−68.3% |
| Adbiotech | Mar 23 | ₩3B | −36.0% | ₩346M | Turned to profit | Turned to profit | 11.6%−15.6% |
| HLB Panagene | Mar 17 | ₩4.2B | +21.9% | −₩1.7B | Bigger loss | Bigger loss | −39.6%−7.8% |
| NeoImmuneTech | Mar 19 | ₩27,007 | Turned to profit | −₩4.2M | Smaller loss | Bigger loss | −15,603.0% |
| Cytogen | Mar 20 | ₩6.5B | +17.2% | −₩2.6B | Bigger loss | Bigger loss | −39.1%−33.8% |
| ENCell | Mar 20 | ₩1.4B | −31.1% | −₩4.9B | Smaller loss | Bigger loss | −342.7%−263.4% |
| KoBioLabs | Mar 19 | ₩15B | −14.4% | −₩3B | Bigger loss | Bigger loss | −19.6%−9.2% |
| Geninus | Mar 16 | ₩3.1B | +114.7% | −₩3B | Smaller loss | Bigger loss | −94.3%−245.8% |
| Aprogen | Mar 23 | ₩32B | −20.5% | −₩27B | Smaller loss | Bigger loss | −85.4%−73.4% |
| GeneOne Life Science | Mar 23 | ₩2.7B | −74.8% | −₩13B | Bigger loss | Bigger loss | −494.9%−93.9% |
| CJ Bioscience | Mar 16 | ₩1.3B | +33.7% | −₩5.2B | Smaller loss | Smaller loss | −410.0%−1,042.2% |
| RPbio | Mar 23 | ₩33B | +6.4% | ₩684M | +91.4% | +150.4% | 2.1%1.1% |
| Gencurix | Mar 16 | ₩2.1B | −11.8% | −₩2.1B | Smaller loss | Bigger loss | −97.3%−91.8% |
| Quratis | Mar 23 | ₩260M | +216.1% | −₩2.2B | Smaller loss | Bigger loss | −834.1%−8,281.2% |
| Oncocross | Mar 19 | ₩141M | −78.5% | −₩2.2B | Smaller loss | Smaller loss | −1,567.1%−362.1% |
| Wonbiogen | Mar 23 | ₩9.4B | +10.1% | ₩2.1B | +40.5% | −12.3% | 22.4%17.6% |
| HLB Pep | Mar 19 | ₩1.5B | +5.1% | −₩3.2B | Bigger loss | Bigger loss | −215.9%−91.3% |
| Organoidsciences | Mar 18 | ₩1.2B | — | −₩3.8B | — | Smaller loss | −313.3% |
| Orientbio | Feb 13 | ₩6.2B | +25.4% | ₩796M | −56.9% | Turned to profit | 12.9%37.5% |
| Kolmar BioTech | Mar 23 | ₩12B | +3.9% | −₩13M | Turned to loss | Smaller loss | −0.1%8.5% |
| Kainos Medicine | — | ₩304M | +326.3% | −₩2.3B | Smaller loss | Bigger loss | −755.8%−5,858.3% |
| IMBdx | Mar 20 | ₩1.7B | +168.6% | −₩2.2B | Smaller loss | Smaller loss | −128.0%−395.7% |
| Eutilex | Mar 19 | ₩2.4B | −9.4% | −₩5B | Smaller loss | Bigger loss | −210.5%−288.9% |
| Aligned Genetics | Mar 23 | ₩4.3B | −23.8% | ₩1.1B | −29.1% | +103.1% | 25.9%27.8% |
| SeouLin Bioscience | Mar 18 | ₩20B | +1.8% | ₩142M | Turned to profit | −81.9% | 0.7%−1.0% |
| Hass | Mar 18 | ₩3.8B | −13.5% | ₩330M | −41.3% | +8.2% | 8.6%12.8% |
| Biotoxtech | — | ₩14B | +24.7% | −₩98M | Smaller loss | Smaller loss | −0.7%−12.3% |
| Genolution | Mar 19 | ₩2.4B | +12.2% | −₩2B | Smaller loss | Smaller loss | −84.8%−97.7% |
| Linkgenesis | — | ₩6.5B | +100.6% | ₩653M | +165.2% | +7.1% | 10.0%7.5% |
| SLSBio(Specialty Lab Solution Bio) | — | ₩341M | −81.3% | −₩1.4B | Bigger loss | Smaller loss | −413.6%−10.7% |
| LabGenomics | Mar 23 | ₩21B | −5.3% | −₩26B | Bigger loss | Bigger loss | −122.0%−25.6% |
| Genematrix | — | ₩2.9B | +9.2% | −₩191M | Smaller loss | Bigger loss | −6.7%−16.6% |
| Dt&Cro | Mar 20 | ₩15B | +29.2% | ₩621M | Turned to profit | Turned to profit | 4.1%−4.7% |
| C&R Research | Mar 17 | ₩15B | +7.1% | ₩93M | Turned to profit | −62.3% | 0.6%−5.3% |
| GFC Life Science | Mar 18 | ₩4.6B | — | ₩80M | — | Turned to profit | 1.8% |
| Shaperon | Mar 19 | ₩48M | Turned to profit | −₩4.4B | Bigger loss | Bigger loss | −9,183.7% |
| Daesung Microbiological Labs | Mar 16 | ₩6.9B | +1.9% | −₩270M | Turned to loss | Turned to loss | −3.9%10.7% |
| Enbioco | Mar 18 | ₩7.7B | +48.3% | −₩729M | Smaller loss | Smaller loss | −9.5%−42.2% |
| MFC | Mar 23 | ₩5B | — | −₩454M | — | Turned to loss | −9.1% |
| WooGene B&Gco | Mar 19 | ₩13B | −0.1% | ₩459M | Turned to profit | Turned to profit | 3.4%−8.3% |
| Xcell Therapeutics | Mar 19 | ₩1.1B | +123.2% | −₩3.3B | Bigger loss | Bigger loss | −306.2%−524.5% |
| Kbio Labs | Mar 23 | ₩28B | +13.9% | ₩1.3B | −10.1% | Turned to profit | 4.6%5.8% |
| PeopleBio | Mar 23 | ₩154M | −76.7% | −₩1.7B | Smaller loss | Smaller loss | −1,133.8%−282.3% |
| Celestra | Mar 24 | −₩1.3B | Turned to loss | −₩168M | Smaller loss | Smaller loss | — |
| Olipass | Mar 20 | ₩129M | Turned to profit | −₩1.7B | Smaller loss | Bigger loss | −1,290.4% |
| From Bio | Mar 23 | ₩20B | +12.0% | −₩8B | Smaller loss | Bigger loss | −41.0%−56.5% |
| NGeneBio | Mar 23 | ₩12B | +1,570.7% | −₩1.9B | Smaller loss | Bigger loss | −15.9%−625.2% |
| Phionx | Apr 21 | ₩666,184 | −67.3% | −₩703,987 | Bigger loss | Smaller loss | −105.7%−27.6% |
| Curachem | Not yet | ||||||
| NovMetaPharma | Not yet | ||||||
| BioInfra | Not yet | ||||||
| 283100 | Not yet | ||||||
| Pharmaresearch Bio | Not yet | ||||||
| Ensol Biosciences | Not yet | ||||||
| Epi Biotech | Not yet | ||||||
| Invites Biocore | Not yet | ||||||
| Plumbline Life Sciences | Not yet | ||||||
| Moogene Medi | Not yet | ||||||
| Imgt | Not yet | ||||||
| 072520 | Not yet | ||||||
| 341170 | Not yet | ||||||
| ProGen | Not yet | ||||||
| Medizen Humancare | Not yet | ||||||
| Cronex | Not yet | ||||||
| BioInfra Life Science | Not yet | ||||||
| 208340 | Not yet | ||||||
| PCL | Not yet | ||||||
| QuadMedicine | Not yet | ||||||
| 258540 | Not yet | ||||||
| Samsung Epis Holdings | Not yet | ||||||
| Ingenia Therapeutics | Not yet | ||||||
| Samyang Biopharm | Not yet | ||||||
| Kanaph Therapeutics | Not yet | ||||||
| Inventera | Not yet | ||||||
| HL Genomics | Not yet | ||||||
| Median Diagnostics | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Technical breadth
After the close on Oct 28, 2026- Above 20-day average
- 13.9%
- Above 60-day average
- 23.1%
- RSI above 70
- 0.6%
- RSI below 30
- 5.2%
- 52-week highs
- 0
- 52-week lows
- 8
Index gauge · Short term
Bearish
0 bullish, 2 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 1 neutral, 7 bearish
Technical read
The Biotech (new drugs) theme covers 170 member stocks, and only 14.1% of them are trading above their 20-day averages while 22.4% are above their 60-day averages. Breadth is weak, with 12 members at 52-week lows and none at 52-week highs, and 7.1% of members sit in RSI oversold territory against 0.6% in overbought territory. The equal-weighted member index is below its cloud with an RSI of 39.5, and both its short-term and medium-term readings are labeled bearish.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
- MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
- MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK ReitSK hynixSK NetworksSK DiscoverySKCSK Telecom
ETFs for this theme
All ETFs →- KoAct Bio Healthcare Active₩298B+₩2.8B
- TIGER Bio TOP 10₩247B−₩2B
- TIME K Bio Active₩207B+₩6.2B
- KODEX Bio₩198B0
- TIGER Healthcare₩132B0
- TIGER Technology Transfer Bio Active₩104B−₩50M
- KODEX Healthcare₩64B−₩1.5B
- TIGER KOSDAQ 150 Biotech₩48B+₩203M
AUM · Flow 1w
Biotech (new drugs)
+0.26%바이오 신약
The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.
204 companies · 110 up · 23 flat · 71 down
- Traded value
- ₩702B
- Value vs 20-day average
- 0.75×
- Top gainer
- 3billion +11.11%
- Largest company
- Samsung Biologics ₩64T
Companies in this theme
| Company | Price | Daily | Traded value | Market cap | NPS |
|---|---|---|---|---|---|
Samsung Biologics207940 · KOSPI | ₩1,372,000 | −0.15% | ₩69B | ₩64T | 6.88% |
Celltrion068270 · KOSPI | ₩189,800 | +0.64% | ₩80B | ₩44T | 7.28% |
Alteogen196170 · KOSDAQ | ₩223,000 | +2.06% | ₩53B | ₩16T | 2.68% |
Samsung Epis Holdings0126Z0 · KOSPI | ₩316,500 | +1.44% | ₩9.3B | ₩7.9T | 5.70% |
SK biopharmaceuticals326030 · KOSPI | ₩75,200 | +0.40% | ₩8.9B | ₩5.9T | 6.00% |
Yuhan000100 · KOSPI | ₩77,300 | −3.38% | ₩27B | ₩5.7T | 6.83% |
HLB028300 · KOSDAQ | ₩40,650 | +1.88% | ₩19B | ₩5.4T | 1.16% |
Hanmi Pharm128940 · KOSPI | ₩369,500 | +5.42% | ₩42B | ₩4.7T | 9.61% |
Hanmi Science008930 · KOSPI | ₩41,450 | +0.12% | ₩11B | ₩2.8T | 6.27% |
SK Bioscience302440 · KOSPI | ₩32,150 | +1.26% | ₩2.2B | ₩2.5T | 5.50% |
PharmaResearch214450 · KOSDAQ | ₩228,500 | −1.30% | ₩44B | ₩2.4T | 7.14% |
ABL Bio298380 · KOSDAQ | ₩41,800 | +2.33% | ₩13B | ₩2.3T | 4.02% |
Hugel145020 · KOSDAQ | ₩181,500 | +1.17% | ₩4.8B | ₩2.3T | 2.29% |
Peptron087010 · KOSDAQ | ₩97,200 | +1.67% | ₩16B | ₩2.3T | 1.63% |
Voronoi310210 · KOSDAQ | ₩121,100 | +1.94% | ₩7.9B | ₩2.3T | 2.78% |
OliX Pharmaceuticals226950 · KOSDAQ | ₩97,300 | +7.40% | ₩22B | ₩2.2T | 5.04% |
Hanall Biopharma009420 · KOSPI | ₩38,500 | +0.65% | ₩7.1B | ₩2T | 10.56% |
D&D Pharmatech347850 · KOSDAQ | ₩42,900 | +5.15% | ₩28B | ₩2T | 1.75% |
Caregen214370 · KOSDAQ | ₩34,350 | +3.15% | ₩1.9B | ₩1.8T | 0.65% |
Mezzion Pharma140410 · KOSDAQ | ₩52,600 | −2.41% | ₩8.6B | ₩1.6T | 0.50% |
ST Pharm237690 · KOSDAQ | ₩77,200 | −3.98% | ₩29B | ₩1.6T | 5.77% |
Seegene096530 · KOSDAQ | ₩33,500 | +2.13% | ₩8.8B | ₩1.6T | 0.64% |
GC Biopharma006280 · KOSPI | ₩130,500 | +1.08% | ₩1.7B | ₩1.5T | 6.68% |
Naturecell007390 · KOSDAQ | ₩22,150 | −0.67% | ₩3.6B | ₩1.4T | 0.44% |
OSCOTECInc039200 · KOSDAQ | ₩36,650 | +2.09% | ₩3.1B | ₩1.4T | 3.87% |
Aimed Bio0009K0 · KOSDAQ | ₩20,850 | +1.46% | ₩2.4B | ₩1.4T | 0.03% |
Kolon TissueGene950160 · KOSDAQ | ₩14,600 | −1.08% | ₩4.9B | ₩1.2T | 0.57% |
Ingenia Therapeutics950260 · KOSDAQ | ₩23,600 | +1.51% | ₩5.8B | ₩1.2T | — |
Daewoong Pharma069620 · KOSPI | ₩99,900 | +0.81% | ₩2.5B | ₩1.2T | 10.30% |
Curiox Biosystems445680 · KOSDAQ | ₩62,400 | +0.16% | ₩7.3B | ₩1.1T | 1.25% |
Chong Kun Dang Pharmaceutical185750 · KOSPI | ₩61,900 | +0.98% | ₩716M | ₩854B | 6.34% |
JS Link127120 · KOSDAQ | ₩18,630 | +2.59% | ₩3B | ₩697B | 5.05% |
Qurient115180 · KOSDAQ | ₩17,970 | −2.55% | ₩2.6B | ₩674B | 3.88% |
L&C Bio290650 · KOSDAQ | ₩24,950 | +4.83% | ₩4.8B | ₩673B | 1.28% |
Chabiotech085660 · KOSDAQ | ₩7,080 | +0.71% | ₩1.2B | ₩658B | 0.31% |
Rznomics476830 · KOSDAQ | ₩23,400 | +3.77% | ₩4B | ₩656B | 3.96% |
G2GBIO456160 · KOSDAQ | ₩37,900 | −3.19% | ₩26B | ₩630B | 2.41% |
Pharmicell005690 · KOSPI | ₩10,230 | +4.39% | ₩4.3B | ₩614B | 2.38% |
Onconic Therapeutics476060 · KOSDAQ | ₩13,070 | +2.35% | ₩1.2B | ₩593B | — |
Proteina468530 · KOSDAQ | ₩51,500 | +5.21% | ₩10B | ₩572B | 3.78% |
JW Pharmaceutical001060 · KOSPI | ₩23,200 | +0.22% | ₩975M | ₩570B | 2.44% |
Hyundai Bioscience048410 · KOSDAQ | ₩5,870 | +0.86% | ₩7.4B | ₩566B | 0.37% |
Medy-Tox086900 · KOSDAQ | ₩65,800 | −2.52% | ₩903M | ₩480B | 1.44% |
BioNote377740 · KOSPI | ₩4,595 | +0.88% | ₩195M | ₩468B | 0.81% |
GI Innovation358570 · KOSDAQ | ₩7,140 | +1.56% | ₩1.3B | ₩461B | 4.07% |
Shinpoong Pharmaceutical019170 · KOSPI | ₩8,460 | +1.32% | ₩1.4B | ₩443B | 0.39% |
GC005250 · KOSPI | ₩9,130 | +1.11% | ₩384M | ₩429B | 5.94% |
Penetrium Bioscience187660 · KOSDAQ | ₩6,660 | +4.88% | ₩5.6B | ₩426B | — |
AbClon174900 · KOSDAQ | ₩21,100 | 0.00% | ₩5.5B | ₩421B | 3.57% |
GemVax & KAEL082270 · KOSDAQ | ₩9,040 | +0.33% | ₩1.1B | ₩411B | 2.55% |
HLB Life Science067630 · KOSDAQ | ₩3,340 | −0.45% | ₩481M | ₩407B | 0.07% |
IL Dong Pharmaceutical249420 · KOSPI | ₩12,790 | +1.11% | ₩1.2B | ₩405B | 2.30% |
Curocell372320 · KOSDAQ | ₩25,000 | +2.46% | ₩1.1B | ₩381B | 0.46% |
Bukwang Pharmaceutical IND003000 · KOSPI | ₩3,750 | −0.13% | ₩818M | ₩370B | 0.68% |
Orum Therapeutics475830 · KOSDAQ | ₩16,360 | +1.80% | ₩1.5B | ₩356B | 0.09% |
AprilBio397030 · KOSDAQ | ₩12,400 | +0.49% | ₩1.3B | ₩342B | 0.95% |
Medipostco078160 · KOSDAQ | ₩8,670 | +2.12% | ₩803M | ₩340B | 1.55% |
Dong-A ST170900 · KOSPI | ₩34,900 | 0.00% | ₩337M | ₩340B | 4.78% |
Samyang Biopharm0120G0 · KOSPI | ₩41,550 | −1.07% | ₩1.1B | ₩309B | 1.73% |
SillaJen215600 · KOSDAQ | ₩2,120 | −0.47% | ₩1.1B | ₩294B | 0.09% |
ToolGen199800 · KOSDAQ | ₩29,800 | +6.24% | ₩854M | ₩291B | 0.43% |
EuBiologics206650 · KOSDAQ | ₩7,620 | +1.60% | ₩551M | ₩277B | 0.17% |
NKGen Biotech Korea182400 · KOSDAQ | ₩3,670 | 0.00% | ₩0 | ₩265B | — |
ImmuneOncia Therapeutics424870 · KOSDAQ | ₩2,870 | +1.41% | ₩1.1B | ₩262B | — |
Genomictree228760 · KOSDAQ | ₩10,400 | +6.89% | ₩641M | ₩259B | 0.51% |
Q AID377460 · KOSDAQ | ₩4,080 | 0.00% | ₩0 | ₩253B | — |
S.Biomedics304360 · KOSDAQ | ₩20,150 | −0.25% | ₩792M | ₩251B | — |
FutureChem220100 · KOSDAQ | ₩8,080 | −4.04% | ₩2.6B | ₩250B | 0.76% |
HLB Therapeutics115450 · KOSDAQ | ₩2,635 | −0.57% | ₩917M | ₩249B | 0.10% |
IntoCell287840 · KOSDAQ | ₩16,300 | +2.00% | ₩351M | ₩245B | 1.04% |
Jetema216080 · KOSDAQ | ₩5,960 | −1.16% | ₩479M | ₩222B | 0.01% |
BioPlus099430 · KOSDAQ | ₩3,360 | +1.20% | ₩275M | ₩207B | 0.42% |
DuChemBio176750 · KOSDAQ | ₩7,160 | +1.70% | ₩2.2B | ₩204B | 0.04% |
Genome&Company314130 · KOSDAQ | ₩3,840 | −1.54% | ₩1B | ₩201B | 0.24% |
GC Genome340450 · KOSDAQ | ₩8,440 | +1.20% | ₩6.7B | ₩200B | — |
Binex053030 · KOSDAQ | ₩6,100 | +0.49% | ₩379M | ₩199B | 2.17% |
3billion394800 · KOSDAQ | ₩6,200 | +11.11% | ₩6.7B | ₩197B | 4.02% |
HEM Pharma376270 · KOSDAQ | ₩27,100 | −4.07% | ₩339M | ₩196B | — |
Bioneercorporation064550 · KOSDAQ | ₩7,070 | 0.00% | ₩1.1B | ₩182B | 0.10% |
curacle365270 · KOSDAQ | ₩8,210 | +3.53% | ₩294M | ₩182B | 0.50% |
Vivozon Pharmaceutical082800 · KOSDAQ | ₩2,915 | −1.52% | ₩279M | ₩177B | — |
Kangstem Biotech217730 · KOSDAQ | ₩1,863 | −0.11% | ₩387M | ₩175B | 0.10% |
Helixmith084990 · KOSDAQ | ₩3,730 | −2.10% | ₩938M | ₩172B | 0.12% |
BNC Korea256840 · KOSDAQ | ₩2,485 | +0.40% | ₩1B | ₩170B | — |
Kolon Life Science102940 · KOSDAQ | ₩12,940 | +1.41% | ₩608M | ₩169B | 0.50% |
Eone Diagnomics Genome Center245620 · KOSDAQ | ₩741 | 0.00% | ₩0 | ₩167B | — |
GC Cell144510 · KOSDAQ | ₩10,470 | −19.15% | ₩3.7B | ₩165B | 0.06% |
Aptabio Therapeutics293780 · KOSDAQ | ₩5,490 | −8.96% | ₩920M | ₩154B | 0.05% |
Cellbion308430 · KOSDAQ | ₩11,940 | +5.48% | ₩281M | ₩154B | — |
ISU Abxis086890 · KOSDAQ | ₩3,595 | +1.70% | ₩232M | ₩147B | 0.20% |
Bio Solution086820 · KOSDAQ | ₩5,590 | −1.06% | ₩322M | ₩145B | 0.15% |
Y-Biologics338840 · KOSDAQ | ₩9,390 | −7.94% | ₩890M | ₩145B | 0.17% |
Aribio Holdings290690 · KOSDAQ | ₩2,700 | −1.28% | ₩650M | ₩143B | — |
Anterogen065660 · KOSDAQ | ₩13,960 | −0.14% | ₩248M | ₩140B | 0.30% |
Cell Biotech049960 · KOSDAQ | ₩14,830 | −0.54% | ₩53M | ₩139B | 0.00% |
Kanaph Therapeutics0082N0 · KOSDAQ | ₩10,030 | +2.24% | ₩866M | ₩133B | — |
JW Shinyak067290 · KOSDAQ | ₩2,375 | +0.64% | ₩2.7B | ₩133B | — |
Ensol Biosciences140610 · KONEX | ₩8,920 | +7.21% | ₩27M | ₩128B | — |
Pharmaresearch Bio217950 · KONEX | ₩29,200 | −0.17% | ₩691,600 | ₩122B | — |
Macrogen038290 · KOSDAQ | ₩11,240 | +1.72% | ₩103M | ₩122B | 4.56% |
TiumBio321550 · KOSDAQ | ₩3,835 | −1.79% | ₩729M | ₩115B | 0.31% |
Keeps Biopharma256940 · KOSDAQ | ₩5,510 | +0.36% | ₩83M | ₩111B | — |
ViGenCell308080 · KOSDAQ | ₩5,040 | −0.59% | ₩512M | ₩103B | 0.59% |
Celemics331920 · KOSDAQ | ₩9,230 | +0.11% | ₩99M | ₩103B | — |
HLB bioStep278650 · KOSDAQ | ₩5,910 | −5.89% | ₩2.5B | ₩103B | — |
Genexine095700 · KOSDAQ | ₩2,250 | −3.23% | ₩437M | ₩102B | 0.15% |
MedPacto235980 · KOSDAQ | ₩2,925 | −2.99% | ₩254M | ₩100B | 2.96% |
Asta246720 · KOSDAQ | ₩6,070 | 0.00% | ₩0 | ₩99B | — |
Metabiomed059210 · KOSDAQ | ₩3,635 | −0.68% | ₩624M | ₩99B | — |
Aribiolab261780 · KOSDAQ | ₩3,405 | +0.15% | ₩629M | ₩99B | — |
CHA AI Healthkare025620 · KOSPI | ₩5,300 | −0.93% | ₩30M | ₩96B | 0.01% |
DreamCIS223250 · KOSDAQ | ₩3,870 | −2.15% | ₩960M | ₩95B | — |
iNtRON Biotechnology048530 · KOSDAQ | ₩3,045 | −0.16% | ₩437M | ₩94B | 1.38% |
Vaxcell-Bio Therapeutics323990 · KOSDAQ | ₩3,955 | −0.25% | ₩495M | ₩92B | 0.07% |
T&R Biofab246710 · KOSDAQ | ₩1,906 | −1.75% | ₩189M | ₩91B | 0.95% |
Corestemchemon166480 · KOSDAQ | ₩1,705 | +2.46% | ₩236M | ₩90B | 0.02% |
Aminologics074430 · KOSDAQ | ₩1,007 | +0.70% | ₩76M | ₩90B | — |
HLB Global003580 · KOSPI | ₩1,772 | −2.96% | ₩673M | ₩90B | 0.29% |
Enzychem Lifesciences183490 · KOSDAQ | ₩990 | 0.00% | ₩0 | ₩84B | 0.30% |
Choong ANG Vaccine Laboratory072020 · KOSDAQ | ₩8,830 | +0.57% | ₩32M | ₩82B | — |
Pharos iBio388870 · KOSDAQ | ₩5,890 | +1.38% | ₩126M | ₩76B | — |
HLB Genex187420 · KOSDAQ | ₩2,300 | +3.14% | ₩260M | ₩75B | — |
Polaris AI Pharma041910 · KOSDAQ | ₩5,640 | +1.99% | ₩145M | ₩75B | — |
Yuhan Pref.000105 · KOSPI | ₩65,200 | 0.00% | ₩66M | ₩75B | — |
SCL Science246960 · KOSDAQ | ₩2,135 | −6.97% | ₩634M | ₩74B | — |
Eye Gene185490 · KOSDAQ | ₩1,717 | −1.83% | ₩339M | ₩74B | 2.40% |
Theragen Etex066700 · KOSDAQ | ₩2,020 | −0.25% | ₩53M | ₩74B | 0.40% |
DongKook Life Science303810 · KOSDAQ | ₩2,275 | −0.22% | ₩309M | ₩73B | — |
Choolip & Sciences291650 · KOSDAQ | ₩2,310 | −3.14% | ₩91M | ₩71B | — |
Inventera0007J0 · KOSDAQ | ₩8,830 | +2.32% | ₩339M | ₩69B | — |
SunBio067370 · KOSDAQ | ₩5,680 | +1.07% | ₩17M | ₩69B | — |
Sugentech253840 · KOSDAQ | ₩4,105 | +0.61% | ₩150M | ₩69B | — |
Naturalendo Tech168330 · KOSDAQ | ₩2,095 | +0.24% | ₩8.7M | ₩67B | 0.10% |
CTC Bio060590 · KOSDAQ | ₩2,685 | −1.29% | ₩85M | ₩65B | — |
Amicogen092040 · KOSDAQ | ₩915 | 0.00% | ₩244M | ₩65B | 0.37% |
Optipharm153710 · KOSDAQ | ₩4,375 | +0.57% | ₩70M | ₩64B | 0.44% |
Pangen Biotech222110 · KOSDAQ | ₩4,640 | +1.31% | ₩24M | ₩63B | — |
PharmGen Science004720 · KOSPI | ₩2,740 | −0.36% | ₩91M | ₩62B | 0.08% |
Abion203400 · KOSDAQ | ₩3,380 | 0.00% | ₩0 | ₩61B | 0.98% |
Cellid299660 · KOSDAQ | ₩2,040 | −4.00% | ₩651M | ₩60B | 0.02% |
Tego Science191420 · KOSDAQ | ₩7,400 | +6.32% | ₩57M | ₩60B | — |
Adbiotech179530 · KOSDAQ | ₩1,909 | −3.73% | ₩89M | ₩59B | — |
HLB Panagene046210 · KOSDAQ | ₩1,300 | +1.09% | ₩158M | ₩59B | — |
NeoImmuneTech950220 · KOSDAQ | ₩1,677 | +0.42% | ₩209M | ₩57B | — |
Cytogen217330 · KOSDAQ | ₩2,475 | +1.02% | ₩138M | ₩57B | — |
Imgt456570 · KONEX | ₩10,630 | −1.57% | ₩16M | ₩56B | — |
HL Genomics0156T0 · KOSDAQ | ₩7,150 | +0.42% | ₩225M | ₩56B | — |
ENCell456070 · KOSDAQ | ₩5,030 | +9.59% | ₩5.2B | ₩55B | — |
KoBioLabs348150 · KOSDAQ | ₩2,720 | −1.09% | ₩31M | ₩53B | — |
Geninus389030 · KOSDAQ | ₩1,305 | −2.25% | ₩651M | ₩51B | — |
QuadMedicine464490 · KOSDAQ | ₩4,365 | +6.72% | ₩352M | ₩50B | — |
Aprogen007460 · KOSPI | ₩1,940 | +1.36% | ₩746M | ₩50B | 0.76% |
GeneOne Life Science011000 · KOSPI | ₩2,670 | 0.00% | ₩0 | ₩49B | 0.19% |
Epi Biotech446440 · KONEX | ₩21,000 | −4.33% | ₩231,000 | ₩48B | — |
CJ Bioscience311690 · KOSDAQ | ₩3,650 | +0.27% | ₩9.2M | ₩48B | — |
RPbio314140 · KOSDAQ | ₩5,300 | +0.57% | ₩18M | ₩46B | — |
Gencurix229000 · KOSDAQ | ₩1,957 | 0.00% | ₩0 | ₩46B | 0.81% |
NovMetaPharma229500 · KONEX | ₩3,455 | +2.07% | ₩81M | ₩45B | — |
Quratis348080 · KOSDAQ | ₩3,495 | +2.79% | ₩56M | ₩45B | — |
Oncocross382150 · KOSDAQ | ₩3,145 | +1.13% | ₩64M | ₩41B | — |
Wonbiogen307280 · KOSDAQ | ₩5,760 | +1.05% | ₩163M | ₩41B | — |
HLB Pep196300 · KOSDAQ | ₩4,100 | −1.09% | ₩44M | ₩39B | — |
Organoidsciences476040 · KOSDAQ | ₩5,900 | +0.85% | ₩65M | ₩39B | 1.38% |
Orientbio002630 · KOSPI | ₩1,288 | −0.69% | ₩30M | ₩38B | 0.06% |
Kolmar BioTech215380 · KOSDAQ | ₩2,140 | +1.90% | ₩90M | ₩36B | — |
Kainos Medicine284620 · KOSDAQ | ₩1,087 | 0.00% | ₩0 | ₩36B | — |
IMBdx461030 · KOSDAQ | ₩2,475 | −1.39% | ₩35M | ₩35B | 0.31% |
Eutilex263050 · KOSDAQ | ₩959 | 0.00% | ₩0 | ₩35B | 0.74% |
Aligned Genetics238120 · KOSDAQ | ₩2,440 | +0.21% | ₩53M | ₩35B | — |
SeouLin Bioscience038070 · KOSDAQ | ₩3,670 | +1.24% | ₩33M | ₩34B | — |
Hass450330 · KOSDAQ | ₩4,125 | +0.73% | ₩6.9M | ₩34B | — |
Biotoxtech086040 · KOSDAQ | ₩2,110 | +1.44% | ₩19M | ₩34B | — |
Genolution225220 · KOSDAQ | ₩1,717 | +0.35% | ₩61M | ₩33B | — |
Linkgenesis219420 · KOSDAQ | ₩2,830 | +1.07% | ₩34M | ₩32B | — |
ProGen296160 · KONEX | ₩2,100 | +1.94% | ₩1.9M | ₩32B | — |
SLSBio(Specialty Lab Solution Bio)246250 · KOSDAQ | ₩1,969 | 0.00% | ₩0 | ₩30B | — |
LabGenomics084650 · KOSDAQ | ₩2,015 | +8.92% | ₩273M | ₩30B | 0.58% |
Genematrix109820 · KOSDAQ | ₩1,432 | −1.24% | ₩26M | ₩29B | — |
Dt&Cro383930 · KOSDAQ | ₩2,000 | −1.48% | ₩102M | ₩26B | — |
C&R Research359090 · KOSDAQ | ₩2,205 | +1.38% | ₩16M | ₩25B | — |
GFC Life Science388610 · KOSDAQ | ₩4,480 | −1.43% | ₩211M | ₩24B | — |
Shaperon378800 · KOSDAQ | ₩2,350 | +0.21% | ₩38M | ₩22B | — |
Daesung Microbiological Labs036480 · KOSDAQ | ₩5,520 | +0.55% | ₩8M | ₩21B | — |
Enbioco352940 · KOSDAQ | ₩1,901 | −1.55% | ₩9.9M | ₩21B | — |
MFC432980 · KOSDAQ | ₩2,275 | −5.01% | ₩12M | ₩20B | — |
WooGene B&Gco018620 · KOSDAQ | ₩2,770 | −1.95% | ₩74M | ₩19B | — |
Plumbline Life Sciences222670 · KONEX | ₩4,635 | 0.00% | ₩0 | ₩19B | — |
Moogene Medi322970 · KONEX | ₩1,810 | −0.55% | ₩267,125 | ₩18B | — |
Xcell Therapeutics373110 · KOSDAQ | ₩1,040 | +3.07% | ₩47M | ₩18B | — |
PCL241820 · KOSDAQ | ₩6,040 | 0.00% | ₩0 | ₩17B | — |
Kbio Labs038530 · KOSDAQ | ₩3,105 | +1.31% | ₩21M | ₩16B | — |
PeopleBio304840 · KOSDAQ | ₩561 | 0.00% | ₩0 | ₩14B | — |
Celestra352770 · KOSDAQ | ₩5,250 | 0.00% | ₩0 | ₩14B | — |
Olipass244460 · KOSDAQ | ₩1,651 | 0.00% | ₩0 | ₩13B | — |
Curachem456190 · KONEX | ₩7,210 | 0.00% | ₩0 | ₩13B | — |
From Bio377220 · KOSDAQ | ₩1,909 | −1.04% | ₩171M | ₩11B | — |
NGeneBio354200 · KOSDAQ | ₩665 | −2.35% | ₩278M | ₩11B | — |
Invites Biocore216400 · KONEX | ₩1,360 | −2.79% | ₩167,554 | ₩10B | — |
Median Diagnostics233250 · KONEX | ₩4,800 | 0.00% | ₩0 | ₩8.4B | — |
BioInfra199730 · KOSDAQ | ₩1,640 | +2.44% | ₩166M | ₩8B | — |
Phionx900100 · KOSDAQ | ₩1,155 | −14.44% | ₩88M | ₩6.1B | — |
Medizen Humancare236340 · KONEX | ₩1,350 | +3.85% | ₩191,200 | ₩4.1B | — |
Cronex215570 · KONEX | ₩600 | −12.41% | ₩634,595 | ₩4B | — |
BioInfra Life Science266470 · KONEX | ₩99 | +4.21% | ₩180,195 | ₩2.8B | — |
Source: KRX statistical information